“Comparative Efficacy of Anastrozole, Letrozole, and Fulvestrant as Endocrine Partners Combined with CDK4/6 Inhibitors in Patients with HR+/HER2– Metastatic Breast Cancer: A Real-World Evidence from the Stavropol Regional Clinical Oncology Center”, Вопр. онкол., vol. 71, no. 6, p. OF-2376, Dec. 2025, doi: 10.37469/0507-3758-2025-71-6-OF-2376.